Apogee Therapeutics, Inc. 3/A SEC Filings

Filed On	Filing
17 Jul 2023	Form 3/A: Dambkowski Carl, Chief Medical Officer Holds 300,788 shares of Common Stock
17 Jul 2023	Form 3/A: Henderson Jane, Chief Financial Officer Holds 206,871 shares of Common Stock
17 Jul 2023	Form 3/A: Henderson Michael Thomas, Director Holds 1,489,487 shares of Common Stock
17 Jul 2023	Form 3/A: Fox Jennifer A., Director Holds 34,824 shares of Common Stock
17 Jul 2023	Form 3/A: Jones William A Jr, Director Holds 34,824 shares of Common Stock

Comments